Concepedia

Ate van der Gaast

AV

Statistics

Publications

105

Citations

15.8K

H-Index

48

Active since

1988

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

Rotterdam University of Applied Sciences

Erasmus MC Cancer Institute

Amsterdam UMC Location University of Amsterdam

Ate van der Gaast is an author at Erasmus MC specializing in medicine, oncology, and esophageal cancer.

Publications per year

1988–2023

105

Publications

105

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot et al. · New England Journal of Medicine · 2012 · 5.5K citations · Full text

, , +14

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.6K citations

, , +17

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · Journal of Clinical Oncology · 2021 · 772 citations · Full text

, , +17

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 576 citations

, , +17

Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

Vera Oppedijk, Ate van der Gaast, J. Jan B. van Lanschot et al. · Journal of Clinical Oncology · 2014 · 511 citations

, , +17

1–5 of 105